Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women

Circulation

Volumn 95, Issue 1, 1997, Pages 39-45

  Schunkert, Heribert ^a   Jan Danser, A H ^b   Hense, Hans Werner ^c,d   Derkx, Frans H M ^b   Kürzinger, Susanne ^a   Riegger, Günter A J ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

angiotensin; estrogen; hormones; menopause; renin

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ESTROGEN;

ALDOSTERONE BLOOD LEVEL; ANGIOTENSIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CORONARY RISK; ESTROGEN THERAPY; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PLASMA RENIN ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN RELEASE;

EID: 16944365095     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.1.39     Document Type: Article

References (9)

1. Lignieres BD, Basdevant A, Thomas G, Thalabard JC, Mercier-Bodard C, Conard J, Guyene TT, Mairon N. Biological effects of estradiol-17β in postmenopausal women: oral versus percutaneous administration. J Clin Endocrinol Metab. 1986;62:536-541.
2. Hassager C, Riis BJ, Strom V, Guyene TT, Christiansen C. The long-term effect of oral and percutaneous estradiol on plasma renin substrate and blood pressure. Circulation. 1987;76:753-758.
3. Laragh JH, Sealey JE, Ledingham JGG, Newton MA. Oral contraceptives: renin, aldosterone and high blood pressure. JAMA. 1967;201:918-922.
4. Skinner SL, Lumbers ER, Symonds EM. Alteration by oral contraceptives of normal menstrual changes in plasma renin activity, concentration and substrate. Clin Sci. 1969;36:67-76.
5. Soveri P, Fyhrquist F. Plasma renin activity and angiotensin II during oral contraception. Ann Clin Res. 1977;9:346-349.
6. Weinberger MH, Kramer NJ, Grim CE, Petersen LP. The effect of posture and saline loading on plasma renin activity and aldosterone concentration in pregnant, non-pregnant and estrogen-treated women. J Clin Endocrinol Metab. 1977;44:69-77.
7. Goldhaber SZ, Hennekens CH, Spark P, Evans DA, Rosner B, Tayler JO, Kass EH. Plasma renin substrate, renin activity, and aldosterone levels in a sample of oral contraceptive users from a community survey. Am Heart J. 1984;107:119-122.
8. Brons M, Jacobsen JG, Kristoffersen K. Changes in plasma renin concentration, activity and substrate after twenty-eight days' treatment with micronized estrogen, ethinylestradiol and norethisteroneacetate in postmenopausal women. Acta Med Scand Suppl. 1981;646:94-97.
9. Punnonen R, Lammimausta R, Erkkola R, Rauramo L. Estradiol valerate therapy and the renin-aldosterone system in castrated woman. Maturitas. 1980;2:91-94.